Antithrombotic Drug Therapy in Cardiovascular Disease (Record no. 110782)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04765nam a22005175i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-60327-235-3 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220084512.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 100715s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781603272353 |
| -- | 978-1-60327-235-3 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-60327-235-3 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC681-688.2 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJD |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED010000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.12 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Askari, Arman T. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Antithrombotic Drug Therapy in Cardiovascular Disease |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Arman T. Askari, A. Michael Lincoff. |
| 264 #1 - | |
| -- | Totowa, NJ : |
| -- | Humana Press : |
| -- | Imprint: Humana Press, |
| -- | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | VIII, 880p. 69 illus., 11 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Contemporary Cardiology |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Basic Principles -- Platelets in Arterial Thrombosis -- The Role of Coagulation in Arterial and Venous Thrombosis -- The Link Between Inflammation and Thrombosis -- The Genetics of Thrombosis -- Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease -- Aspirin in Primary and Secondary Prevention of Cardiovascular Disease -- Thienopyridines in Stable Coronary Disease -- Antithrombotic Therapy for NSTE ACS -- Antiplatelet Therapies in Unstable Angina and Non-ST Segment Elevation Myocardial Infarction -- Unfractionated Heparin and Enoxaparin for the Management of Non-ST-Segment Elevation Acute Coronary Syndromes -- Direct Thrombin Inhibitors in Acute Coronary Syndromes -- Synthetic Factor Xa Inhibition in Acute Coronary Syndromes -- Antithrombotic Therapy for STEMI -- Antiplatelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors for the Management of ST-Segment Elevation Myocardial Infarction -- Antithrombin Therapy for Acute ST-Segment Elevation Myocardial Infarction -- Fibrinolysis and Facilitated PCI -- Antithrombotic Therapy in Interventional Cardiology -- Antithrombotic Therapy in Percutaneous Coronary Intervention -- Antithrombotic Therapy in Carotid and Peripheral Intervention -- Monitoring of Antithrombotic Therapies in Interventional Cardiology -- Antithrombotic Therapy in Venous Thromboembolism -- Venous Thromboembolism -- Fibrinolysis for Pulmonary Embolism -- Duration of Anticoagulant Therapy After Venous Thromboembolism -- Clinical Consideration -- Antithrombotic Therapy for Atrial Fibrillation and Cardioversion -- Antithrombotic Therapy for Valvular Heart Disease -- Antithrombotic Therapy in Heart Failure and Cardiomyopathy -- Heparin-Induced Thrombocytopenia -- Resistance to Antiplatelet Drugs. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT). |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Interventional radiology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cardiology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Vascular Surgery. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cardiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal Medicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Interventional Radiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Vascular Surgery. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lincoff, A. Michael. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781603272346 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Contemporary Cardiology |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-60327-235-3 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.